Prestigious research universities that develop their own patents appear no more likely to enjoy sovereign immunity at the Patent and Trademark Office than Indian tribes that buy theirs.

The U.S. Court of Appeals for the Federal Circuit signaled strongly Monday that its same rationale for turning away Native American sovereign immunity last summer in Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals will apply equally to state sovereign immunity.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]